Karl Hård
Patrimonio netto: 99 420 $ in data 31/05/2026
Patrimonio netto: 99 420 $ in data 31/05/2026
Karl J.
Hård is currently VP-Investor Relations & Business Development at Egetis Therapeutics AB since 2022.
Former positions include Investor Relations Contact at AstraZeneca PLC, Assistant Professor at the University of Leiden, Head-Investor Relations & Corporate Communications at Redx Pharma Plc from 2016 to 2017, and Head-Investor Relations & Communications at Kiadis Pharma NV from 2017 to 2018.
Education includes a doctorate from the University of Utrecht and graduate studies at the University of Helsinki.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 150.982 ( 0,03% ) | 99 420 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EGETIS THERAPEUTICS AB | Contatto Relazioni con gli Investitori | 01/02/2022 |
| Società | Posizione | Fine |
|---|---|---|
| KIADIS PHARMA N.V. | Contatto Relazioni con gli Investitori | 31/12/2018 |
| REDX PHARMA LTD | Contatto Relazioni con gli Investitori | 02/07/2017 |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Redx Pharma Plc
Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale